What Patients Should Know About Integrative Care for Colon Cancer

Patients who search for integrative care after a colon cancer diagnosis quickly encounter a confusing landscape. Some sources promise that diet or supplements alone can resolve the disease, while others dismiss every complementary therapy as unproven. Neither extreme serves patients well, and the stakes of getting this decision wrong are real. Colon cancer is among the most treatable solid tumors when it is managed with surgery and, when indicated, chemotherapy, which is why the choices a patient makes about integrative care should always strengthen that foundation rather than compete with it.

At The Center for Advanced Medicine, Dr. Jonathan Stegall and our clinical team speak with patients and families every week who are trying to sort reliable guidance from marketing. Our practice is devoted exclusively to cancer care, and our view is consistent: integrative oncology is complementary, physician-supervised care that works alongside conventional treatment. The questions patients bring to us are thoughtful and deserve direct answers. What follows are the points we believe every person considering integrative care for colon cancer should understand before making decisions.

Integrative Care Versus Alternative Care: A Distinction That Matters

The most important concept for any patient to understand is the difference between integrative and alternative care. Integrative oncology combines evidence-informed complementary therapies, such as nutrition counseling, exercise guidance, and mind-body practices, with standard oncologic treatment. Alternative care, by contrast, uses unproven methods in place of surgery, chemotherapy, radiation, or immunotherapy. These are not two versions of the same idea, and the difference has measurable consequences for survival.

Research published by Johnson and colleagues in the Journal of the National Cancer Institute in 2018 examined patients with nonmetastatic cancers who chose alternative medicine alone instead of conventional treatment. Those patients had a substantially higher risk of death than patients who received standard care, and the association was especially pronounced among those with colorectal cancer. A companion analysis by Johnson and colleagues in JAMA Oncology in 2018 found that patients who used complementary medicine were more likely to decline some part of recommended conventional treatment, and that refusal, rather than the complementary therapy itself, appeared to account for their poorer survival. The lesson for patients is clear: complementary care is most appropriate when it helps someone complete their recommended treatment, not when it becomes a reason to delay or decline it.

This is the framework that guides our Signature Integrative Oncology approach. Dr. Stegall is a member of both the American Society of Clinical Oncology (ASCO) and the Society for Integrative Oncology (SIO), and his philosophy, described on our page on what integrative oncology is, rejects both the idea that conventional therapy should be discarded and the idea that nothing outside the standard of care has value. Latte-Naor and Mao, writing in the Journal of Oncology Practice in 2019, described this same model: integrative oncology is patient-centered and evidence-informed, and it is delivered in coordination with the oncology team rather than as a parallel system.

Common Questions Patients Ask About Integrative Care

Patients rarely arrive with a single question. More often, they carry a mix of hope, fear, and fatigue from reading conflicting advice online. We have found that most concerns fall into a few recurring themes, and addressing each one honestly helps patients make well-informed decisions with their families and their oncologists.

Will Integrative Care Interfere With My Chemotherapy?

This is a legitimate concern, and the honest answer is that it depends on what is being used. Some complementary approaches, such as structured exercise, dietary guidance, and stress-reduction practices, carry little risk of interaction and have supportive evidence. Other products, particularly high-dose antioxidant supplements and certain herbal preparations, may interact with chemotherapy metabolism or potentially blunt its effect. Ambrosone and colleagues, reporting in the Journal of Clinical Oncology in 2020, found that breast cancer patients who took antioxidant supplements before and during chemotherapy had a higher hazard of recurrence, a finding that has prompted many oncologists to counsel caution with self-directed supplement use during treatment.

At The Center for Advanced Medicine, every supplement, IV therapy, and medication is reviewed by Dr. Stegall in the context of each patient’s full treatment plan. We ask patients to bring everything they are currently taking to their first visit, including over-the-counter products. Our goal is to reduce the chance of an unwanted interaction and to keep the patient’s oncology team informed of anything we recommend.

Is There Evidence Behind These Therapies?

The strength of evidence varies considerably across complementary therapies, and patients deserve transparency about that. Some interventions have been evaluated in large randomized trials and are now reflected in national guidelines, while others have earlier-stage or mechanistic data that remain under active study. We believe patients should know which category a recommendation falls into before agreeing to it. Dr. Stegall describes his own approach as open-minded skepticism, meaning that a therapy is considered only when there is a scientific rationale and a reasonable safety profile.

Can I Keep My Current Oncologist?

Yes, and we encourage it. Many of our patients continue to receive surgery, chemotherapy, or radiation through their existing oncology team while working with us on supportive care. Coordinated communication is central to how we practice, and it helps prevent the fragmentation that can occur when patients see several clinicians without a shared plan.

Complementary Options and How Our Team Personalizes Care

Integrative care for colon cancer is not a fixed menu, and each plan at The Center for Advanced Medicine is developed by Dr. Jonathan Stegall and our team of expert clinicians based on the stage of disease, the conventional treatment already underway or recommended, laboratory findings, nutritional status, and each patient’s goals and values. Candidacy is part of this process rather than a separate checklist. Patients with significant organ dysfunction, active infection, uncontrolled bleeding, or those who are considering stopping recommended conventional treatment require particularly careful discussion, and some therapies may not be appropriate for them. Our page on integrative colon cancer care outlines the components that may be considered.

Exercise: Among the Strongest Evidence in Colon Cancer

For patients with colon cancer, the evidence supporting structured exercise has become notably strong. Courneya and colleagues published results of the CHALLENGE trial in the New England Journal of Medicine in 2025, a randomized study of patients with resected colon cancer who had completed adjuvant chemotherapy. Participants assigned to a structured, coached exercise program had significantly longer disease-free survival than those who received health-education materials alone. For this reason, we view physical activity as a clinical intervention rather than a lifestyle suggestion, and we tailor recommendations to each patient’s surgical recovery, energy level, and baseline fitness.

Nutrition Guidance That Respects the Individual

Nutrition is often the first area patients want to address, and it is also where misinformation is most common. Our nutrition and cancer services focus on helping patients maintain adequate calorie and protein intake, manage treatment-related digestive symptoms, and support gut health after bowel surgery. Recommendations are individualized to medical history, laboratory results, cultural food traditions, and personal preferences, since a plan a patient cannot realistically follow offers little benefit. We avoid extreme restriction during active treatment, when unintended weight loss may reduce resilience.

Adjunctive Therapies and Monitoring

Depending on the clinical picture, Dr. Stegall may discuss adjunctive options offered at our practice, including mistletoe therapy, IV vitamin C, lymphatic therapy, mind-body medicine, and carefully selected repurposed medications. He may also discuss low-dose chemotherapy with insulin potentiation therapy (IPT), including how it differs from standard dosing, so that patients and their oncologists can weigh it thoughtfully. Monitoring is equally important. Tools such as Signatera circulating tumor DNA testing may provide additional information alongside imaging and standard tumor markers, and results are interpreted in the context of each patient’s overall care.

What to Expect From Integrative Colon Cancer Care

Patients often ask what integrative care will feel like in practice and what outcomes are realistic. We believe in setting honest expectations from the first conversation. Integrative care may help patients feel stronger, manage symptoms more effectively, and maintain nutrition and activity through treatment, but it cannot promise a cure or guarantee the absence of side effects. No reputable integrative oncologist should make those claims.

The First Visit

The process begins with an initial consultation in which Dr. Stegall reviews pathology, imaging, operative reports, prior treatment, and current medications. This visit is unhurried by design, since meaningful personalization requires understanding the full context of a patient’s diagnosis and life. Patients are welcome to bring a family member or caregiver, and we encourage them to arrive with written questions.

Ongoing Care and Follow-Up

After the initial evaluation, a written plan is developed and revisited regularly as treatment progresses. Laboratory values, symptom patterns, weight, and functional status help guide adjustments. Some services, such as consultations and nutrition follow-up, may be available by telemedicine, while treatments that require clinical supervision are provided at our clinic in Alpharetta, Georgia, which welcomes patients from across the country. Throughout, we maintain communication with each patient’s oncology team so that everyone is working from the same information.

Questions to Ask Before Starting Any Integrative Program

Whether a patient chooses our practice or another, we believe certain questions help separate responsible integrative care from approaches that may put patients at risk. A thoughtful provider will welcome these questions and answer them directly. Patients should be cautious of any program that discourages them from asking or that cannot explain its reasoning.

Useful questions include: is this care intended to complement my recommended surgery, chemotherapy, or radiation, or to replace it? What published evidence supports each therapy, and how strong is it? Could any supplement or IV therapy interact with my current treatment? Will you communicate directly with my oncologist, and who is supervising my care?

At The Center for Advanced Medicine, care is directed by physicians, and Dr. Stegall completed his internal medicine residency through the Yale University School of Medicine and a fellowship in integrative oncology through the Metabolic Medical Institute, affiliated with the University of South Florida Morsani College of Medicine; you can read more about his background on our page about Dr. Stegall. Our team also includes R. Douglas Wichman, MD, a board-certified radiologist who also holds a degree in naturopathic medicine.

Schedule a Consultation With Dr. Stegall

A colon cancer diagnosis brings difficult decisions, and patients should not have to navigate integrative care on their own or through conflicting online advice. At The Center for Advanced Medicine, Dr. Jonathan Stegall and our clinical team offer thoughtful, physician-supervised integrative care designed to complement conventional colon cancer treatment and support quality of life. Our Signature Integrative Oncology approach is built on transparency about evidence, careful attention to safety, and respect for each patient’s values and goals.

If you or someone you love is living with colon cancer and would like to understand how integrative care may fit alongside your current treatment, we invite you to request a consultation. Our team will review your history, answer your questions candidly, and help you decide on next steps with your oncology team. You can reach our office at (470) 335-0314 or through our online consultation request form.